Plasmodium vivax the first-line treatment for "P. falciparum" malaria, it may also be used for P. vivax malaria in combination with primaquine for radical cure. An exception is artesunate plus sulfadoxine-pyrimethamine (AS+SP), which is not effective against P. vivax in many places. Mefloquine is a good alternative and in some countries is more readily available. Atovaquone-proguanil is an effective alternative in patients unable to tolerate chloroquine. Quinine may be used to treat "vivax" malaria but is associated with inferior outcomes. 32–100% of patients will relapse following successful treatment of "P. vivax" infection if a radical cure (eradication of liver stages) is not
This Is What the Edge of Your Seat Was Made For This Is What the Edge of Your Seat Was Made For This Is What the Edge of Your Seat Was Made For is the first release by Bring Me the Horizon, released on 25 September 2004, through Thirty Days of Night Records in Australia and on 30 January 2005, through Visible Noise records in the UK. "This Is What the Edge of Your Seat Was Made For" was released on 25 September 2004 in the US through Earache Records. The original pressing, on Thirty Days of Night Records, was a strict run of only 1,000 copies. Its title comes from